NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Receivables - Other (2014 - 2025)

NextPlat's (NXPL) quarterly Receivables - Other came in at $1.9 million in Q4 2025, up 45.0% year-over-year from $1.3 million in Q4 2024, and up 12.47% quarter-over-quarter from $1.7 million in Q3 2025.

Analysis

NextPlat (NXPL) Receivables - Other (2014 - 2025) Analysis & Trends

NextPlat (NXPL) has reported Receivables - Other for 12 consecutive years, with $1.9 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Receivables - Other rose 45.0% year-over-year to $1.9 million in Q4 2025; TTM through Dec 2025 was $1.9 million, a 45.0% increase from a year earlier, with the FY2025 full-year figure at $1.9 million, up 45.0% from the prior year.
  • Receivables - Other was $1.9 million for Q4 2025 at NextPlat, up from $1.7 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $2.9 million in Q3 2023 and troughed at $77623.0 in Q1 2021.
  • A 5-year average of $929933.5 and a median of $854000.0 in 2025 frame the typical range for Receivables - Other.
  • Across the five-year window, Receivables - Other surged 2347.12% in 2023 and slumped 58.07% in 2024, its largest moves.
  • Over 5 years, Receivables - Other stood at $100422.0 in 2021, then soared by 41.4% to $142000.0 in 2022, then jumped by 1200.0% to $1.8 million in 2023, then fell by 27.9% to $1.3 million in 2024, then surged by 45.0% to $1.9 million in 2025.
  • The last three Receivables - Other figures came in at $1.9 million (Q4 2025), $1.7 million (Q3 2025), and $854000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.93 Mn
Sep 30, 2025 1.72 Mn
Jun 30, 2025 854,000.00
Mar 31, 2025 1.72 Mn
Dec 31, 2024 1.33 Mn
Sep 30, 2024 1.24 Mn
Jun 30, 2024 1.01 Mn
Mar 31, 2024 2.07 Mn
Dec 31, 2023 1.85 Mn
Sep 30, 2023 2.95 Mn
Jun 30, 2023 175,410.00
Dec 31, 2022 142,000.00
Sep 30, 2022 120,359.00
Jun 30, 2022 120,816.00
Mar 31, 2022 92,144.00
Dec 31, 2021 100,422.00
Sep 30, 2021 97,909.00
Jun 30, 2021 85,727.00
Mar 31, 2021 77,623.00
Dec 31, 2020 75,556.00